VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $633,000 | +60.3% | 23,698 | +53.7% | 0.00% | +50.0% |
| Q2 2019 | $395,000 | +9.1% | 15,418 | -4.7% | 0.00% | 0.0% |
| Q1 2019 | $362,000 | +7.7% | 16,177 | +1.6% | 0.00% | 0.0% |
| Q4 2018 | $336,000 | +9.4% | 15,928 | -3.9% | 0.00% | 0.0% |
| Q3 2018 | $307,000 | -13.5% | 16,581 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $355,000 | +0.3% | 15,923 | -1.1% | 0.00% | 0.0% |
| Q1 2018 | $354,000 | -9.7% | 16,103 | -4.5% | 0.00% | 0.0% |
| Q4 2017 | $392,000 | -55.0% | 16,866 | -55.5% | 0.00% | -60.0% |
| Q3 2017 | $871,000 | +198.3% | 37,926 | +186.0% | 0.01% | +150.0% |
| Q2 2017 | $292,000 | -60.9% | 13,259 | -59.5% | 0.00% | -60.0% |
| Q1 2017 | $746,000 | +10.7% | 32,761 | +1.5% | 0.01% | +25.0% |
| Q4 2016 | $674,000 | +119.5% | 32,261 | +177.3% | 0.00% | +100.0% |
| Q3 2016 | $307,000 | -6.1% | 11,635 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $327,000 | – | 11,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |